Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease and Obesity Treatment
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 3, pp. 220-228
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
Amélio F. Godoy‐Matos, Wellington S. Silva Júnior, Cynthia Melissa Valério
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 478
Polysaccharide from Rosa roxburghii Tratt Fruit Attenuates Hyperglycemia and Hyperlipidemia and Regulates Colon Microbiota in Diabetic db/db Mice
Lei Wang, Chao Li, Qiang Huang, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 68, Iss. 1, pp. 147-159
Closed Access | Times Cited: 153
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Eda Kaya, Yusuf Yılmaz
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 2, pp. 329-338
Open Access | Times Cited: 125
Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018
Yancheng Song, Wencong Guo, Zhaopeng Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
GLP-1a: Going beyond Traditional Use
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 71
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
Yu Xu, Wei Guo, Cheng Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 112
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1525-1525
Open Access | Times Cited: 83
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 27
Fruit and vegetable intake and the risk of non-alcoholic fatty liver disease: a meta-analysis of observational studies
Rui Wang, Ruijuan Yan, Junzhe Jiao, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 8
The growing range of complications of diabetes mellitus
Peter Shane Hamblin, Anthony Russell, Stella Talic, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 1
The Role of TLRs in Obesity and Its Related Metabolic Disorders
Tannia Isabel Campos-Bayardo, Daniel Román-Rojas, Andrés García-Sánchez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2229-2229
Open Access | Times Cited: 1
Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice
Yinhua Ni, Fen Zhuge, Mayumi Nagashimada, et al.
Free Radical Biology and Medicine (2019) Vol. 152, pp. 571-582
Closed Access | Times Cited: 60
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
Manon Allaire, Jordi Bruix, Marko Korenjak, et al.
JHEP Reports (2022) Vol. 4, Iss. 12, pp. 100578-100578
Open Access | Times Cited: 35
Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases
Dan Wu, Huiying Wang, Lijun Xie, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, et al.
Canadian Journal of Gastroenterology and Hepatology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 30
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
Èlia Navarro‐Masip, Núria Mestres Petit, Marta Zorzano-Martínez, et al.
Obesity Surgery (2024) Vol. 34, Iss. 3, pp. 841-849
Closed Access | Times Cited: 7
Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials
Mohamed Abuelazm, Islam Mohamed, Ahmed Naeem, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 4, pp. 371-381
Closed Access | Times Cited: 7
The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study
Amalie London, Michael M. Richter, Kim A. Sjøberg, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 2, pp. 283-293
Open Access | Times Cited: 7
Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis
Jijiao Wu, Wen Lin, Xiaolian Liu, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 6
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients
Pınar HAMURCU, Eda Kaya, Emel Alphan, et al.
European Journal of Gastroenterology & Hepatology (2019) Vol. 32, Iss. 10, pp. 1352-1357
Closed Access | Times Cited: 49
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
Yijie Li, Brittney O. Baumert, Nikos Stratakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 4, pp. 332-345
Open Access | Times Cited: 5
Metabolic dysfunction-associated steatotic liver disease: A silent pandemic
Arghya Samanta, Moinak Sen Sarma
World Journal of Hepatology (2024) Vol. 16, Iss. 4, pp. 511-516
Open Access | Times Cited: 5
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity
L Horvath, Miloš Mráz, Edward B. Jude, et al.
Drugs (2024) Vol. 84, Iss. 8, pp. 933-952
Open Access | Times Cited: 5
Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Sara Karjoo, Anthony Auriemma, Teresa Fraker, et al.
Obesity Pillars (2022) Vol. 3, pp. 100027-100027
Open Access | Times Cited: 19
GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
Ernest Adeghate
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 223-232
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top